Apellis Pharmaceuticals
Price & Volume
Stats
See more52W Range | $16.10-$42.47 |
Market Cap | $2.2B |
Shares Short | 25M |
Financials
See moreRevenue (12 Mos) | $775.8M |
Revenue Growth (YoY) | -3.2% |
Gross Profit (12 Mos) | $314.6M |
Diluted EPS | -$1.80 |
News
See moreYahoo Finance • 2 days ago
Apellis Pharma general counsel Watson sells $93k in stock
Yahoo Finance • 14 days ago
Apellis and Sobi Announce EMPAVELI® (pegcetacoplan) Showed Sustained Efficacy at One Year in Phase 3 Study for C3G and Primary IC-MPGN
Yahoo Finance • last month
Apellis Pharmaceuticals Reports First Quarter 2025 Financial Results
Yahoo Finance • 2 months ago
Is Apellis Pharmaceuticals, Inc. (APLS) Among the Best Guru Stocks to Buy According to Wall Street Analysts?
About
CEO | Dr. Cedric Francois M.D., Ph.D. |
CFO | Mr. Timothy E. Sullivan |
Address | 100 Fifth Avenue, Waltham, MA, United States, 02451 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 705 |
